M-APIXABAN

mantra pharma inc🇨🇦 Health Canada

Approval Id: 0a1edcfb14d1b899
Drug Approval Canada Name: M-APIXABAN
Product Name: M-APIXABAN
Status: Marketed
Status Date: 2022-09-21
Original Market Date: 2022-09-21
Din: 02529017
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.04.14
Atc Original: B01AF02 APIXABAN
Atc Name: b 01 af 02
Aig Number: 0153051002
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

APIXABAN

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0a1edcfb14d1b899

Type

Standard